Generated by All in One SEO v5.0.1.1, this is an llms.txt file, used by LLMs to index the site. # The Vaccine Group (TVG) The Vaccine Group (TVG) develops herpesvirus-based viral-vector vaccines for livestock and companion animals, with expanding applications in biotherapeutics. ## Sitemaps - [XML Sitemap](https://thevaccinegroup.com/sitemap.xml): Contains all public & indexable URLs for this website. ## Posts - [News](https://thevaccinegroup.com/news/) - Read the latest news from TVG, including animal vaccine research, scientific breakthroughs, partnerships, funding, and company updates. - [The Vaccine Group Welcomes Two New Directors to its Board](https://thevaccinegroup.com/tvg-appoints-frontier-ip-ceo-and-head-of-medical-school-at-university-of-plymouth-to-board-of-directors/) - The Vaccine Group (TVG) is pleased to announce the appointment of Neil Crabb and Professor Laura Bowater, MBE, to its Board of Directors. Neil Crabb joins the board as Frontier IP’s representative, succeeding Matthew White. As Chief Executive and founder of Frontier IP, Neil brings extensive experience in investing in and supporting technology companies and - [TVG CEO contributes expertise to international animal health research discussions in Ottawa](https://thevaccinegroup.com/tvg-ceo-contributes-expertise-to-international-animal-health-research-discussions-in-ottawa/) - TVG CEO Dr Jeremy Salt contributed expertise at STAR IDAZ International Research Consortium meeting in Ottawa, helping shape future animal health research priorities. - [TVG accepted as a member of the Global African Swine Fever Research Alliance](https://thevaccinegroup.com/tvg-accepted-as-a-member-of-gara/) - TVG is delighted to announce today that our application for membership of GARA has been accepted. - [TVG and partners to trial new vaccine to tackle bacterial infection in pigs](https://thevaccinegroup.com/tvg-and-partners-to-trial-new-vaccine-to-tackle-bacterial-infection-in-pigs/) - TVG and partners have been awarded over £1million to develop a cross protective vaccine for Streptococcus suis in pigs - [TVG’s Chief Scientific Officer recognised by The University of Plymouth](https://thevaccinegroup.com/tvgs-chief-scientific-officer-recognised-by-the-university-of-plymouth/) - The Vaccine Group (“TVG”) is delighted to be able to congratulate our Chief Scientific Officer (CSO), Dr Michael Jarvis, on his promotion to Professor in Virology and Immunology at The University of Plymouth, England (“UoP”). This promotion acknowledges Professor Jarvis’s commitment and contributions to the University, where he has been part of the academic staff - [TVG to work with Roslin Institute to progress bovine tuberculosis vaccine development](https://thevaccinegroup.com/tvg-to-work-with-roslin-institute-to-progress-bovine-tuberculosis-vaccine-development/) - TVG are partnering with the Roslin Institute to carry out small scale animal trials on a new bovine TB vaccine candidate - [TVG is an Innovation Showcase Finalist](https://thevaccinegroup.com/tvg-is-an-innovation-showcase-finalist/) - TVG has been selected as an Innovation Showcase Finalist at Animal Health, Nutrition & Technology Innovation, Asia 2024 Jeremy Salt, TVG CEO, will be representing TVG at the summit meeting 7-8th October in Tokyo. This will be a great opportunity to showcase TVG’s progress, especially in developing improved swine vaccines. Jeremy is looking forward to - [TVG Sponsors Graduation Awards for Top Biomedical Science Students](https://thevaccinegroup.com/tvg-sponsors-graduation-awards-for-top-biomedical-science-students/) - In July 2024, The Vaccine Group (TVG) proudly sponsored the graduation awards for the highest achievers in all three years of the BSc Biomedical Science (Hons) Degree at the University of Plymouth. The recipient of the Year Three Award was Ella Cooper (pictured above receiving her award from our Lab Manager, Angela Ward and Dr - [TVG awarded funding to further develop their vaccine platform](https://thevaccinegroup.com/tvg-awarded-funding-to-further-develop-their-vaccine-platform/) - TVG is delighted to announce that they have been awarded funding from the UK’s Bacterial Vaccines Network (BactiVac) - [Innovate UK Smart grant awarded to The Vaccine Group & APHA for cattle vaccine platform development](https://thevaccinegroup.com/innovate-uk-smart-grant-awarded-to-the-vaccine-group-apha-for-cattle-vaccine-platform-development/) - Innovate UK has awarded a £400,000 grant to work on cattle vaccine candidates for bovine respiratory syncytial virus and lumpy skin disease, two major cattle diseases. - [2025 a year of pivotal trial data for TVG](https://thevaccinegroup.com/2025-a-year-of-pivotal-trial-data-for-tvg/) - TVG looks forward to multiple read outs from trials on candidate animal vaccines across the course of 2025. - [TVG and Syva sign option to license agreement for important pig vaccine](https://thevaccinegroup.com/tvg-and-syva-sign-option-to-license-agreement-for-important-pig-vaccine/) - TVG has started a collaboration with the Spanish animal health company Syva for the development of a vaccine against Streptococcus suis - [TVG CEO discusses Syva partnership](https://thevaccinegroup.com/tvg-ceo-discusses-syva-partnership/) - Jeremy Salt, TVG's CEO talked with Proactive about developments in the business. - [TVG CEO joins Global African Swine Fever Research Alliance executive committee](https://thevaccinegroup.com/tvg-ceo-joins-global-african-swine-fever-research-alliance-executive-committee/) - TVG CEO, Dr Jeremy Salt, has been selected to act as Finance Director on the GARA Executive Committee. - [TVG African Swine Fever vaccine candidate enters animal trials](https://thevaccinegroup.com/tvg-african-swine-fever-vaccine-candidate-enters-animal-trials/) - Trials of the African Swine Fever vaccine candidate are already underway at The Pirbright Institute to demonstrate protection against this global epidemic. - [The Vaccine Group shows outstanding performance of its BRSV vaccine candidate in calves](https://thevaccinegroup.com/the-vaccine-group-shows-outstanding-performance-of-its-brsv-vaccine-candidate-in-calves/) - TVG's BRSV vaccine candidate shows compelling results in recent animal trials. TVG is now in discussion with potential commercial partners. - [TVG Streptococcus suis success underpins vaccine delivery platform potential](https://thevaccinegroup.com/tvg-streptococcus-suis-success-underpins-vaccine-delivery-platform-potential/) - S suis vaccine challenge trial results demonstrated enhanced protection compared to current commercial vaccines in cross-serotype protection - [TVG CEO Jeremy Salt discusses S suis vaccine progress](https://thevaccinegroup.com/tvg-ceo-jeremy-salt-discusses-s-suis-vaccine-progress/) - Listen to TVG's CEO, Jeremy Salt, discuss recent progress with TVG's S suis vaccine candidate - [TVG's BRSV vaccine recognised among the UK's major animal research breakthroughs in 2025](https://thevaccinegroup.com/tvgs-brsv-vaccine-recognised-among-the-uks-major-animal-research-breakthroughs-in-2025/) - The Vaccine Group’s bovine respiratory syncytial virus (BRSV) vaccine programme has been recognised in the 2025 Animal Research Breakthroughs Review. - [TVG Award winner at 2023 University of Plymouth graduation](https://thevaccinegroup.com/tvg-award-winner-at-2023-university-of-plymouth-graduation/) - TVG sponsored the graduation awards for the highest achievers in all three years of the BSc Biomedical Science (hons) Degree at the University of Plymouth. - [Pioneering partnership to improve swine health](https://thevaccinegroup.com/pioneering-partnership-to-improve-swine-health/) - The Vaccine Group (TVG), Plymouth is partnering with The Pirbright Institute, Surrey on a new project that sets out to control African swine fever. - [TVG to collaborate on novel vaccine development with DiaGen Ai](https://thevaccinegroup.com/tvg-to-collaborate-on-novel-vaccine-development-with-diagen-ai/) - TVG has entered into a Technology Evaluation Agreement with DiaGen Ai to combine Diagen's AI engine for antigen design with TVG's herpesviral delivery technology - [TVG announces appointment of Advisory Board](https://thevaccinegroup.com/the-vaccine-group-announces-appointment-of-advisory-board/) - TVG has appointed three high-ranking and well-connected animal health experts to form an advisory board to support scale up of the Company’s novel herpesvirus-based vaccine platform - [TVG Lassa fever vaccine makes progress](https://thevaccinegroup.com/lassa-fever-vaccine-makes-progress/) - Vaccine was shown to be immunogenic in inoculated animals, transmissible and reduced Lassa fever virus infection after challenge at highly significant levels. - [TVG extends its portfolio of animal vaccine candidates into new disease areas](https://thevaccinegroup.com/tvg-new-animal-vaccine-candidates/) - TVG is creating new animal vaccine candidates including canine leishmaniasis, feline immunodeficiency virus, lumpy skin disease virus, equine influenza, ovine enzootic abortion and porcine cysticercosis. - [TVG to collaborate on PRRS Immunology Group Grant to Progress Novel PRRS Vaccine](https://thevaccinegroup.com/tvg-to-collaborate-on-prrs-immunology-group-grant-to-progress-novel-prrs-vaccine/) - The Pirbright Institute has received an Impact Acceleration Award to progress a novel vaccine for porcine reproductive and respiratory syndrome (PRRS) with TVG - [Journal of General Virology article published](https://thevaccinegroup.com/journal-of-general-virology-article-published/) - TVG and collaborators work on isolating and sequencing mastomys CMVs has been published in the Journal of General Virology. - [S&P Global Interview: TVG eyes investment to support newly extended vaccine pipeline](https://thevaccinegroup.com/sp-global-interview-tvg-eyes-investment-to-support-newly-extended-vaccine-pipeline/) - TVG’s CEO Jeremy Salt met with S&P Global Animal Health at the recent VetHealth Global forum on Canada’s Prince Edward Island to discuss plans to fund the recently extended vaccine pipeline. Read about the interview below. [pdf-embedder url=”http://thevaccinegroup.com/wp-content/uploads/TVG_eyes_investment_to_support_newly_extended_vaccine_pipeline.pdf”] - [TVG is speaking at the Bactivac Network 4th Annual Network Meeting](https://thevaccinegroup.com/tvg-is-speaking-at-the-bactivac-network-4th-annual-network-meeting/) - TVG will be presenting progress on the S. suis vaccine programme - [BioSeed 2023 - look out for TVG](https://thevaccinegroup.com/bioseed-2023-look-out-for-tvg/) - Dr Jeremy Salt, CEO, will be attending BioSeed 2023 on behalf of The Vaccine Group. A great opportunity to talk about TVG and meet up with a thriving biotech network. - [VetHealthGlobal - see you there!](https://thevaccinegroup.com/vethealthglobal-see-you-there/) - Dr Jeremy Salt will be attending the VetHealthGlobal meeting in Prince Edward Island next week. A great opportunity to meet with potential collaborators and investors. - [TVG Future Biotechnologists interview](https://thevaccinegroup.com/tvg-future-biotechnologists-interview/) - TVG's CEO Jeremy Salt was interviewed recently for the online series 'Future Biotechnologists'. Read the story here. - [Successful Streptococcus suis vaccine project completion](https://thevaccinegroup.com/streptococcus_suis_vaccine_completion/) - TVG successfully completes Anglo-Chinese Streptococcus suis vaccine project backed by Innovate UK - [TVG CEO discusses completion of recent projects](https://thevaccinegroup.com/tvg-ceo-discusses-completion-of-recent-projects/) - TVG CEO, Jeremy Salt, discusses the recent successful completion of the Streptococcus suis and transmissible Lassa fever vaccine projects. - [TVG successfully completes DARPA-funded transmissible Lassa fever vaccine project](https://thevaccinegroup.com/tvg-successfully-completes-darpa-funded-transmissible-lassa-fever-vaccine-project/) - Successful completion of project has demonstrated efficacy of a transmissible lassa fever vaccine for mastomys rats in lab trials. A potential route to reducing human infection with this deadly disease. - [TVG appoints a new Laboratory Manager](https://thevaccinegroup.com/tvg-appoints-a-new-laboratory-manager/) - As TVG prepares for future growth a new position of Laboratory Manager has been created and we are delighted to announce that after an extensive recruitment campaign Angela Ward has been appointed to the role and will start work on 12th August. Angela has performed a similar role at the Marine Biology Association in Plymouth - [TVG Chief Scientific Officer receives National Institute of Health Award](https://thevaccinegroup.com/dr-michael-jarvis-recognised-in-2021-nih-director-awards/) - Dr Michael Jarvis recognised in 2021 NIH Director Awards - [The Vaccine Group announces significant milestone in development of next generation COVID-19 vaccine](https://thevaccinegroup.com/the-vaccine-group-announces-significant-milestone-in-development-of-next-generation-covid-19-vaccine/) - Trial data show strong T cell responses to SARS-CoV-2 and SARS-CoV-1, demonstrating potential for broad immunity against current and future variants of the causal agent of COVID-19 - [The Vaccine Group enters collaboration with The Pirbright Institute and ECO Animal Health Group plc](https://thevaccinegroup.com/the-vaccine-group-enters-collaboration-with-the-pirbright-institute-and-eco-animal-health-group-plc/) - The Vaccine Group (“TVG” or the “Company”) today announces it is to collaborate with The Pirbright Institute (“Pirbright” or the “Institute”) to develop vaccine candidates to combat the porcine respiratory and reproductive syndrome virus (“PRRSV”) in a project supported and funded by ECO Animal Health Group plc (“ECO”). Under the terms of the agreement, ECO - [The Vaccine Group appoints GALVmed Chief Scientific Officer Jeremy Salt as Chief Executive Officer](https://thevaccinegroup.com/the-vaccine-group-appoints-galvmed-chief-scientific-officer-jeremy-salt-as-chief-executive-officer/) - The Vaccine Group (“TVG” or the “Company”) is pleased to announce the appointment of Dr Jeremy Salt as Chief Executive Officer. Jeremy has extensive experience in senior roles in animal healthcare across organisations in the commercial and not-for-profit sectors. He is joining TVG from GALVmed, a not-for-profit organisation that develops and makes available livestock vaccines, medicines and diagnostics ## Pages - [Homepage](https://thevaccinegroup.com/) - TVG develops next-generation animal vaccines using viral vector technology. Discover our innovative solutions for livestock and companion animal health. - [Sitemap](https://thevaccinegroup.com/sitemap/) - Sitemap Sitemap for the TVG website showing all live pages and posts across the site for easy navigation and search engine optimisation – if it’s not listed here then it’s not available anywhere. Pages Cookie Policy Diseases interactive overview Terms & Conditions Privacy Policy Pipeline Science Resources About News Homepage Contact Posts The Vaccine Group - [Resources](https://thevaccinegroup.com/resources/) - Find links to sources of information related to everything we do at TVG. - [About](https://thevaccinegroup.com/about/) - Learn about TVG's expertise in animal vaccine development and viral vector technology. Discover our mission, platform, leadership, and innovation pipeline. - [Careers (No Current Vacancies)](https://thevaccinegroup.com/no-vacancies/) - Explore career opportunities at TVG and submit a speculative application. Join our mission to develop innovative animal vaccines and biotherapeutics. - [Contact](https://thevaccinegroup.com/contact/) - Contact TVG to discuss animal vaccine development, research collaborations, partnerships, licensing opportunities, and business enquiries. - [Pipeline](https://thevaccinegroup.com/pipeline/) - Explore TVG's animal vaccine and biotherapeutic pipeline, addressing major livestock diseases and unmet needs in companion animal health. - [Science](https://thevaccinegroup.com/science/) - Explore TVG's viral vector vaccine platform, development process, and biotherapeutic technologies for livestock and companion animal health. - [Diseases interactive overview](https://thevaccinegroup.com/disease/) - Diseases Companion Animals Livestock Wildlife All target animals Bacteria Helminths Protozoa Virus All pathogens Read more Read more Read more Read more Read more Read more Read more Read more Read more Read more Read more Read more ## Diseases - [Feline immunodeficiency virus](https://thevaccinegroup.com/disease/fiv/) - Feline immunodeficiency virus (FIV) affects cats worldwide. Explore symptoms, transmission, disease impact, and vaccine research from The Vaccine Group (TVG). - [Bovine tuberculosis](https://thevaccinegroup.com/disease/bovine-tuberculosis/) - Bovine tuberculosis (bTB) affects cattle worldwide. Explore symptoms, transmission, economic impact, prevention, and vaccine research from The Vaccine Group (TVG). - [Equine influenza](https://thevaccinegroup.com/disease/equine-influenza/) - Equine influenza affects horses worldwide. Explore symptoms, transmission, disease impact, prevention, and vaccine research from The Vaccine Group (TVG). - [Porcine reproductive and respiratory syndrome (PRRS)](https://thevaccinegroup.com/disease/porcine-reproductive-and-respiratory-syndrome-prrs/) - Porcine reproductive and respiratory syndrome (PRRS) affects pigs worldwide. Explore symptoms, transmission, economic impact, and research from The Vaccine Group. - [Canine leishmaniasis](https://thevaccinegroup.com/disease/canine-leishmaniasis/) - Canine leishmaniasis affects dogs worldwide. Explore symptoms, transmission, disease impact, and vaccine research from The Vaccine Group (TVG). - [Ovine enzootic abortion](https://thevaccinegroup.com/disease/ovine-enzootic-abortion/) - Ovine enzootic abortion (OEA) affects sheep and goats worldwide. Explore symptoms, transmission, economic impact, and research from The Vaccine Group (TVG). - [Porcine cysticercosis](https://thevaccinegroup.com/disease/porcine-cysticercosis/) - Porcine cysticercosis affects pigs and can impact animal and human health. Explore symptoms, transmission, and vaccine research from The Vaccine Group (TVG). - [Porcine circovirus](https://thevaccinegroup.com/disease/porcine-circovirus/) - Porcine circovirus (PCV) affects pig health and productivity worldwide. Explore symptoms, transmission, economic impact, and research from The Vaccine Group. - [Lumpy skin disease](https://thevaccinegroup.com/disease/lumpy-skin-disease/) - Lumpy skin disease (LSD) affects cattle worldwide. Explore symptoms, transmission, economic impact, prevention, and vaccine research from The Vaccine Group (TVG). - [Streptococcus suis](https://thevaccinegroup.com/disease/streptococcus-suis/) - Streptococcus suis affects pigs worldwide. Explore symptoms, transmission, economic impact, prevention, and vaccine research from The Vaccine Group (TVG). - [Bovine respiratory syncytial virus](https://thevaccinegroup.com/disease/bovine-respiratory-syncytial-virus/) - Bovine respiratory syncytial virus (BRSV) affects cattle worldwide. Explore symptoms, transmission, economic impact, and research from The Vaccine Group (TVG). - [Bovine mastitis](https://thevaccinegroup.com/disease/bovine-mastitis/) - Bovine mastitis affects dairy cattle worldwide. Explore symptoms, transmission, economic impact, prevention, and vaccine research from The Vaccine Group (TVG). - [African swine fever (ASF)](https://thevaccinegroup.com/disease/african-swine-fever/) - African swine fever (ASF) affects pigs worldwide. Explore symptoms, transmission, economic impact, and vaccine development by The Vaccine Group. - [Ebola](https://thevaccinegroup.com/disease/ebola/) - Ebola virus disease (EVD) is an increasingly frequent but unpredictable emerging deadly zoonotic disease in people and nonhuman primates, including gorillas. ## Categories - [News](https://thevaccinegroup.com/category/news/) - [Publications](https://thevaccinegroup.com/category/publications/) - [S suis](https://thevaccinegroup.com/category/ssuis/) - [Events](https://thevaccinegroup.com/category/events/) - [BRSV](https://thevaccinegroup.com/category/brsv/) - [Company Updates](https://thevaccinegroup.com/category/company-updates/) - [Porcine](https://thevaccinegroup.com/category/porcine/) - [Cattle](https://thevaccinegroup.com/category/cattle/) - [bTB](https://thevaccinegroup.com/category/btb/) ## Tags - [News S suis](https://thevaccinegroup.com/tag/news_s_suis/) - News related to S suis ## Targets - [Livestock](https://thevaccinegroup.com/animal_type/livestock/) - [Pigs](https://thevaccinegroup.com/animal_type/pigs/) - [Cattle](https://thevaccinegroup.com/animal_type/cattle/) - [Companion Animals](https://thevaccinegroup.com/animal_type/companion-animals/) - [Cats](https://thevaccinegroup.com/animal_type/cats/) - [Dogs](https://thevaccinegroup.com/animal_type/dogs/) - [Wildlife](https://thevaccinegroup.com/animal_type/wildlife/) - [Horses](https://thevaccinegroup.com/animal_type/horses/) ## Pathogens - [Virus](https://thevaccinegroup.com/pathogen_type/virus/) - [Bacteria](https://thevaccinegroup.com/pathogen_type/bacteria/) - [Protozoa](https://thevaccinegroup.com/pathogen_type/protozoa/) - [Helminths](https://thevaccinegroup.com/pathogen_type/helminths/)